Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Prior vaccinations may help protect against Alzheimer's disease

Prior vaccinations may help protect against Alzheimer's disease

Only a small percentage of older adults with early Alzheimer's eligible for new treatments

Only a small percentage of older adults with early Alzheimer's eligible for new treatments

Multimodal intervention approach shows promise in managing and reversing cognitive impairment

Multimodal intervention approach shows promise in managing and reversing cognitive impairment

Mild cognitive impairment linked to decline in decision-making abilities

Mild cognitive impairment linked to decline in decision-making abilities

Androgen deprivation therapy increases the risk of depression, dementia, Alzheimer’s disease, and Parkinson’s disease

Androgen deprivation therapy increases the risk of depression, dementia, Alzheimer’s disease, and Parkinson’s disease

Brazilian researchers propose a quantitative diagnostic method for autism spectrum disorder

Brazilian researchers propose a quantitative diagnostic method for autism spectrum disorder

AI tool can identify social determinants of health in dementia patients

AI tool can identify social determinants of health in dementia patients

New Alzheimer’s drug raises hopes — along with questions

New Alzheimer’s drug raises hopes — along with questions

Scientists discover a therapeutic target for Alzheimer's disease

Scientists discover a therapeutic target for Alzheimer's disease

New pathway for HIV to enter nucleus of healthy cells identified

New pathway for HIV to enter nucleus of healthy cells identified

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Study detects biomarker changes nearly 30 years before symptom onset of Alzheimer’s disease

Study detects biomarker changes nearly 30 years before symptom onset of Alzheimer’s disease

Dementia risk may increase with long-term use of acid reflux drugs

Dementia risk may increase with long-term use of acid reflux drugs

Tau PET shows promise for early diagnosis and treatment of Alzheimer's disease

Tau PET shows promise for early diagnosis and treatment of Alzheimer's disease

Stem cell transplants may be a promising therapeutic against Alzheimer's, study shows

Stem cell transplants may be a promising therapeutic against Alzheimer's, study shows

Are mushrooms an effective early dietary intervention for Alzheimer’s Disease?

Are mushrooms an effective early dietary intervention for Alzheimer’s Disease?

Physical exercise mitigates risk of sleep disturbances due to cadmium exposure

Physical exercise mitigates risk of sleep disturbances due to cadmium exposure

Research uncovers potential route to treating vascular dementia

Research uncovers potential route to treating vascular dementia

Air pollution linked to increased use of community mental health services in people with dementia

Air pollution linked to increased use of community mental health services in people with dementia

$11 million NIH grant focuses on cognitive function in Down syndrome-associated Alzheimer’s

$11 million NIH grant focuses on cognitive function in Down syndrome-associated Alzheimer’s

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.